Skip to main content

Population Genetics, Agilent Reach Licensing Agreement for VeriTag

NEW YORK (GenomeWeb News) – Population Genetics Technologies today said that it has exclusively licensed patent rights covering its VeriTag technology to Agilent Technologies.

The deal covers US Patent No. 8,481,292, entitled "Increasing confidence of allele calls with molecular counting." Veritag quantifies genomic variants down to .1 percent, Population Genetics said on its website, adding it "relies on the ligation of random DNA tags to genomes" prior to PCR amplification "thus uniquely labeling each molecule."

The Cambridge, UK-based firm retains exclusive rights to develop and commercialize the VeriTag technology for applications in human infectious disease diagnostics, as well as non-exclusive rights for veterinary diagnostics and plant genomic uses, it said.

Financial and other terms of the deal were not disclosed.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.